Bank of America Raises CME Group (NASDAQ:CME) Price Target to $216.00

CME Group (NASDAQ:CMEGet Free Report) had its price objective upped by Bank of America from $209.00 to $216.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Bank of America‘s price objective indicates a potential upside of 2.40% from the stock’s current price.

Several other analysts have also recently commented on CME. Keefe, Bruyette & Woods increased their target price on CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a report on Friday, April 5th. Morgan Stanley lifted their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $187.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday. Finally, Barclays upped their price target on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research report on Monday, April 8th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $217.80.

View Our Latest Analysis on CME Group

CME Group Stock Performance

Shares of CME opened at $210.94 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market capitalization of $75.94 billion, a PE ratio of 24.00, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49. CME Group has a 12-month low of $175.73 and a 12-month high of $223.80. The business’s fifty day moving average price is $214.73 and its 200 day moving average price is $211.90.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.42 EPS. Equities research analysts forecast that CME Group will post 9.58 EPS for the current year.

Institutional Trading of CME Group

Several large investors have recently modified their holdings of CME. Vanguard Group Inc. grew its holdings in shares of CME Group by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after acquiring an additional 215,044 shares during the period. Capital World Investors lifted its position in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares in the last quarter. Capital International Investors lifted its holdings in shares of CME Group by 0.4% during the 4th quarter. Capital International Investors now owns 12,739,369 shares of the financial services provider’s stock valued at $2,683,012,000 after buying an additional 50,626 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after buying an additional 189,842 shares during the period. Finally, Parnassus Investments LLC lifted its holdings in shares of CME Group by 0.4% during the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after buying an additional 23,583 shares during the period. 87.75% of the stock is owned by institutional investors.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.